Rapid Micro Biosystems, Inc.
RPID
$2.70
-$0.05-1.82%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 0.79% | -12.33% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 0.79% | -12.33% | |||
| Cost of Revenue | 2.73% | -6.02% | |||
| Gross Profit | -31.93% | -58.82% | |||
| SG&A Expenses | 8.91% | 8.11% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 2.88% | 2.27% | |||
| Operating Income | -4.18% | -14.00% | |||
| Income Before Tax | -5.25% | -16.34% | |||
| Income Tax Expenses | 57.14% | 177.78% | |||
| Earnings from Continuing Operations | -5.28% | -16.52% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -5.28% | -16.52% | |||
| EBIT | -4.18% | -14.00% | |||
| EBITDA | -4.79% | -15.37% | |||
| EPS Basic | -3.75% | -15.94% | |||
| Normalized Basic EPS | -3.69% | -15.70% | |||
| EPS Diluted | -3.75% | -15.94% | |||
| Normalized Diluted EPS | -3.69% | -15.70% | |||
| Average Basic Shares Outstanding | 1.49% | 0.51% | |||
| Average Diluted Shares Outstanding | 1.49% | 0.51% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||